Viatris (VTRS) Total Debt (2019 - 2026)
Viatris (VTRS) posted quarterly Total Debt of $14.3 billion for Q1 2026, down 9.53% year-over-year from $15.9 billion in Q1 2025, and down 0.51% quarter-over-quarter from $14.4 billion in Q4 2025.
Viatris (VTRS) Total Debt (2019 - 2026) Analysis & Trends
Viatris' Total Debt history runs 8 years deep, the most recent figure standing at $14.3 billion for Q1 2026.
- In Q1 2026, Total Debt fell 9.53% year-over-year to $14.3 billion; the TTM figure through Mar 2026 stood at $14.3 billion (down 9.53% YoY), while the FY2025 annual figure was $14.4 billion, up 2.67% from the prior year.
- Total Debt for Q1 2026 stood at $14.3 billion, down from $14.4 billion in the prior quarter.
- The five-year high for Total Debt was $20.0 billion in Q2 2022, with the low at $14.0 billion in Q4 2024.
- The 5-year median for Total Debt is $17.1 billion (2023), against an average of $16.9 billion.
- The sharpest annual moves came in 2024 and 2025: Total Debt fell 22.53% in 2024, then grew 2.67% in 2025.
- Viatris' Total Debt stood at $19.3 billion in 2022, then dropped by 5.97% to $18.1 billion in 2023, then dropped by 22.53% to $14.0 billion in 2024, then climbed by 2.67% to $14.4 billion in 2025, then dropped by 0.51% to $14.3 billion in 2026.
- Business Quant data shows VTRS's Total Debt at $14.3 billion in Q1 2026, $14.4 billion in Q4 2025, and $14.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 760.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.35 Bn |
| Mar 31, 2026 | 14.34 Bn |
| Dec 31, 2025 | 14.41 Bn |
| Sep 30, 2025 | 14.44 Bn |
| Jun 30, 2025 | 14.47 Bn |
| Mar 31, 2025 | 15.85 Bn |
| Dec 31, 2024 | 14.04 Bn |
| Sep 30, 2024 | 15.98 Bn |
| Jun 30, 2024 | 16.40 Bn |
| Mar 31, 2024 | 17.97 Bn |
| Dec 31, 2023 | 18.12 Bn |
| Sep 30, 2023 | 17.08 Bn |
| Jun 30, 2023 | 17.27 Bn |
| Mar 31, 2023 | 18.27 Bn |
| Dec 31, 2022 | 19.27 Bn |
| Sep 30, 2022 | 19.48 Bn |
| Jun 30, 2022 | 19.97 Bn |
| Mar 31, 2022 | 19.42 Bn |
| Dec 31, 2021 | 21.58 Bn |
| Sep 30, 2021 | 21.74 Bn |